×
About 655 results

ALLMedicine™ Addison's Disease Center

Research & Reviews  220 results

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyper...
https://doi.org/10.20945/2359-3997000000392
Archives of Endocrinology and Metabolism; Lousada LM, Mendonca BB et. al.

Jul 21st, 2021 - Primary adrenal insufficiency (PAI) is characterized by the inability of the adrenal cortex to produce sufficient amounts of glucocorticoids and/or mineralocorticoids. Addison's disease (AD) and congenital adrenal hyperplasia (CAH) are the most fr...

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254246
Orphanet Journal of Rare Diseases; Wang YB, Wang O et. al.

Jul 5th, 2021 - Autoimmune polyendocrine syndrome type 1 (APS1) is a hereditary disease caused by mutations in the AIRE gene with both endocrine and non-endocrine organ involvement. The existing data from China are limited, and this study aims to describe the phe...

X-linked congenital adrenal hypoplasia: a case presentation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204446
BMC Endocrine Disorders; Ouyang H, Chen B et. al.

Jun 17th, 2021 - Most patients with congenital adrenal hypoplasia (AHC) develop symptoms during infantile and juvenile periods, with varying clinical manifestations. AHC is a disease that is easily misdiagnosed as Addison's disease or congenital adrenal hyperplasi...

Characteristics of patients with type 1 diabetes and additional autoimmune disease in t...
https://doi.org/10.1210/clinem/dgab376
The Journal of Clinical Endocrinology and Metabolism; Prinz N, Tittel SR et. al.

Jun 2nd, 2021 - Autoimmune diseases affect ~8% of the population. Type 1 diabetes mellitus (T1DM) is linked to other autoimmune diseases (AID) like autoimmune thyroid disease, or Addison's disease (AD) that may impact diabetes therapy and outcome. To analyze demo...

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
https://doi.org/10.1007/s40618-021-01585-6 10.1056/NEJM199006283222601 10.1016/S1571-5078(07)00212-7 10.1056/NEJMra1713301 10.1016/j.autrev.2017.11.012 10.1136/jmg.29.11.824 10.1210/jc.2006-1873 10.1111/j.1399-0004.2006.00690.x 10.1515/JPEM.2006.19.11.1343 10.1016/j.lpm.2012.10.005 10.1515/JPEM.2004.17.6.917 10.1210/edrv.23.3.0466 10.1111/j.1365-2796.2009.02090.x 10.1590/S0004-27302012000100009 10.1016/j.autrev.2010.08.019 10.1016/j.coi.2016.07.003 10.1111/imm.12831 10.1111/j.1365-2265.2008.03318.x 10.3389/fimmu.2013.00331 10.1086/302145 10.1007/s004390050891 10.1210/jcem.83.4.4682 10.1002/humu.1178 10.1530/EJE-08-0328 10.1530/EJE-07-0843 10.1111/j.1365-2265.2009.03740.x 10.1210/jc.2017-00139 10.1530/EC-17-0022 10.1016/j.clim.2018.09.012 10.1007/s004390050846 10.1210/mend.12.8.0143 10.1530/eje.0.1430497 10.1210/jcem.86.10.7884 10.1210/jcem.87.2.8209 10.1210/jc.2002-021495 10.1007/BF03345295 10.1111/j.1365-2265.2008.03206.x 10.1007/s00431-007-0599-4 10.1016/j.clim.2010.12.021 10.1210/jc.2011-2461 10.1016/j.gene.2012.03.032 10.1159/000363537 10.1111/j.1365-2796.2009.02090.x 10.1111/j.1365-2265.2010.03862.x 10.1097/01.mpg.0000239739.09983.38 10.1056/NEJMoa0706487 10.3389/fendo.2018.00463 10.1182/asheducation-2017.1.181 10.1016/j.clml.2012.06.006 10.1016/S0025-6196(12)61377-9 10.1177/039463201002300331 10.1111/j.1365-2265.2008.03340.x 10.1530/EJE-08-0550 10.1210/clinem/dgaa140 10.1530/EJE-18-0313 10.1007/s40618-019-01079-6 10.1016/j.fertnstert.2005.04.060 10.1210/jc.2011-0414 10.1111/cei.12303 10.1210/jc.2012-2734 10.1016/j.clim.2015.03.012 10.1111/j.1749-6632.2002.tb02986.x 10.1001/jama.2019.21565 10.3390/ijms17071106 10.1002/humu.20224 10.1016/j.immuni.2015.04.021 10.1111/imm.12831
Journal of Endocrinological Investigation; Garelli S, Dalla Costa M et. al.

May 19th, 2021 - Autoimmune Polyglandular Syndrome type 1 (APS-1) is a rare recessive inherited disease, caused by AutoImmune Regulator (AIRE) gene mutations and characterized by three major manifestations: chronic mucocutaneous candidiasis (CMC), chronic hypopara...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  8 results

Biomarker(s) for Glucocorticoids
https://clinicaltrials.gov/ct2/show/NCT02152553

Jul 2nd, 2017 - The investigators have shown that patients with adrenal insufficiency (Addison's disease), a rare disorder, have doubled the expected mortality rate in Sweden despite Standard of Care glucocorticoid (GC) replacement. One % of the Swedish populatio...

Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT01840189

Feb 1st, 2017 - The conventional glucocorticoid replacement therapy in primary adrenal insufficiency (Addison's disease) renders the cortisol levels unphysiological, which may cause symptoms and long-term complications. The majority of Addison's patients have oth...

Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency
https://clinicaltrials.gov/ct2/show/NCT00915343

Jul 20th, 2015 - Adrenal insufficiency is a disease with more than 80% 1-year mortality before the availability of synthetic glucocorticoids. Current replacement therapy has improved this dramatically, but recent data suggest that outcome is still compromised. Pat...

Glucocorticoid Treatment in Addison's Disease
https://clinicaltrials.gov/ct2/show/NCT01063569

Mar 20th, 2013 - Addison's disease is a rare condition which in most cases is caused by autoimmune destruction of the adrenals, leading to deficiency of cortisol, aldosterone and adrenal androgens. Unrecognized the disease is life threatening, but with proper trea...

Revival of Stem Cells in Addison's Study
https://clinicaltrials.gov/ct2/show/NCT01371526

Feb 6th, 2013 - Autoimmune Addison's disease (AAD) is a rare and debilitating disease in which an autoimmune attack progressively destroys the adrenal cortex. Untreated it is universally fatal and treated people are absolutely dependent upon steroid medications l...

see more →

News  17 results

Fast Five Quiz: Can You Identify and Treat Hyperkalemia?
https://reference.medscape.com/viewarticle/849260_1

May 26th, 2020 - Hyperkalemia—serum potassium greater than approximately 5.0-5.5 mEq/L in adults—is associated with kidney disease, a diet high in potassium, and drugs that impair renal potassium excretion. It can also appear in infants or children with certain ge...

Fast Five Quiz: Can You Identify and Treat Hyperkalemia?
https://reference.medscape.com/viewarticle/849260

May 26th, 2020 - Hyperkalemia—serum potassium greater than approximately 5.0-5.5 mEq/L in adults—is associated with kidney disease, a diet high in potassium, and drugs that impair renal potassium excretion. It can also appear in infants or children with certain ge...

Malpractice Case: You're Liable, Even if Your EHR Malfunctions
https://www.medscape.com/viewarticle/919804

Nov 4th, 2019 - Notwithstanding the usual suspects that hinder electronic health record (EHR) implementation—initial costs, interoperability problems, training burdens, and altered physician-patient dynamics—there's also the risk of a pure system malfunction. In ...

Malpractice Case: You're Liable, Even if Your EHR Malfunctions
https://www.staging.medscape.com/viewarticle/919804

Nov 4th, 2019 - Notwithstanding the usual suspects that hinder electronic health record (EHR) implementation—initial costs, interoperability problems, training burdens, and altered physician-patient dynamics—there's also the risk of a pure system malfunction. In ...

Malpractice Case: Watch Out for Drug Interactions and Overuse
https://www.medscape.com/viewarticle/916976

Aug 21st, 2019 - Medscape Editor's Key Notes: While on the lookout for signs of drug abuse, physicians should also monitor for drug interactions and simple overuse. Physicians or a care team member should keep an eye on medication management. Ask about medications...

see more →

Patient Education  6 results see all →